“Monsanto claims that GMOs are simultaneously equivalent to existing foods (relieving them of any real duty to demonstrate safety), and novel enough that they can be patented. Despite the Frankensteinian effects of genetic manipulation on proteins and gene expression, these foods have never been studied in a human population, let alone assessing for long-term effects. What happens as a result of this fast-track-to-market process is that slow-emerging trends of harm at the population level begin to emerge. Differing patterns of chronic disease in Europe and America at this point may have some relation to limitations of GMO products in Europe. There is inherent difficulty in associating cause to effect in chronic disease; however, arguing for the importance of long-term premarketing trials.